PLUS THERAPEUTICS INC (PSTV) Stock Income Statement
NASDAQ:PSTV - US72941H5090 - Common Stock
0.4676 USD
+0.01 (+1.65%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.32M | 5.82M | 4.91M | 220.00K | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 18.09M | 20.52M | 18.23M | 19.94M | 12.17M | |||
| Research and Development | 8.05M | 10.58M | 9.69M | 9.70M | 5.32M | |||
| Selling, General, and Administrative Expenses | 10.04M | 9.94M | 8.54M | 10.24M | 6.85M | |||
| Operating Income | -12.77M | -14.70M | -13.32M | -19.71M | -12.17M | |||
| Interest Income/Expense | -6.20M | -3.45M | 5.00K | -560.00K | -910.00K | |||
| Other Income/Expense | -58.00K | 5.17M | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | -320.00K | |||
| Income Before Taxes | -19.03M | -12.98M | -13.32M | -20.28M | -13.40M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -19.03M | -12.98M | -13.32M | -20.28M | -13.40M | |||
| EBITDA | -12.15M | -13.97M | -12.69M | -19.09M | -11.77M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.03 | -1.95 | -4.24 | -11.58 | -16.54 | |||
| Non GAAP EPS | -2.03 | -2.17 | -4.53 | -12.60 | -1.13 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | -357.85% | -222.84% | -271.04% | -9218.18% | N/A | |||
| Operating Profit Margin | -240.23% | -252.32% | -271.14% | -8959.09% | N/A | |||
All data in USD